DexCom (DXCM) Tops Q2 EPS by 3c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $78.57 --0%
EPS Growth %: +9.8%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
PHAR, EEFT, INIO, More
EPS Growth %: +9.8%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
PHAR, EEFT, INIO, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.12 billion.
GUIDANCE:
DexCom sees FY2025 revenue of $4.6-4.625 billion, versus the consensus of $4.611 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Independent Bank (IBCP) Misses Q3 EPS by 11c
- JetBlue Airways (JBLU) Misses Q3 EPS by 7c
- BofA: '1Q27 domestic growth was lowered by -80bps to +3.0%, as AAL, UAL, JBLU, and DAL reduced schedules'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
